Sean Dodge
Stock Analyst at RBC Capital
(1.97)
# 3,111
Out of 4,975 analysts
131
Total ratings
31.4%
Success rate
-3%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.38 | +77.78% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $1.20 | +191.67% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $187.68 | +43.86% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $7.82 | +53.45% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $174.88 | +50.39% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $9.61 | +76.90% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $28.13 | +13.76% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $18.82 | -68.12% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $91.48 | +14.78% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $15.62 | +8.83% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $37.27 | -8.77% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $19.92 | -29.70% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.00 | +150.00% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $23.29 | +20.25% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $15.83 | -11.56% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $185.48 | -82.21% | 1 | Sep 14, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.38
Upside: +77.78%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $1.20
Upside: +191.67%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $187.68
Upside: +43.86%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $7.82
Upside: +53.45%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $174.88
Upside: +50.39%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $9.61
Upside: +76.90%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $28.13
Upside: +13.76%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $18.82
Upside: -68.12%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $91.48
Upside: +14.78%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $15.62
Upside: +8.83%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $37.27
Upside: -8.77%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $19.92
Upside: -29.70%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.00
Upside: +150.00%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $23.29
Upside: +20.25%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $15.83
Upside: -11.56%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $185.48
Upside: -82.21%